Four simple yardsticks can be used in assessing the value of medical treatment for peptic ulcer: remission of symptoms, demonstration of ulcer healing, clinical evidence of relapse and the occurrence of complications. The rates of clinical relapse and remission of symptoms are subjective guides and so are clearly open to observer bias. It is important, therefore, that when these standards are used the clinical observer should not be aware of which patients are receiving the test and which the control treatment. Complication rates of bleeding and perforation are simple and obvious measures but, at least in the United Kingdom, these manifestations are too infrequent to be useful in comparing different treatments.
Radiological assessment of ulcer healing, preferably by a radiologist who does not know the treatments in use, offers a good objective measure of response to treatment for gastric ulcer, but the radiological assessment of healing of duodenal ulcer is impeded by the difficulties of distinguishing scarring from active ulceration.
Gastric Ulcer
Carbenoxolone sodium is now a well proven drug for gastric ulcer (Doll et al. 1962 , Doll et al. 1965 , Horwich & Galloway 1965 , Bank et al. 1967 ). Its use is often complicated by fluid retention; this tends to be dose-related as is the rate of ulcer healing (Doll et al. 1968 ). Prompt treatment with thiazide diuretics together with a potassium supplement will reverse the fluid retention, the potassium supplement being particularly important because carbenoxolone occasionally, and thiazides frequently, cause hypokalbmia. Spironolactone, the only other drug which has been used to prevent fluid retention, curiously blocks both this and ulcer healing (Doll et al. 1968 ). Treatment would be considerably simplified by a liquorice derivative without side-effects and three trials have so far been described using a preparation from which almost all the glycyrrhizinic acid (the fraction from which carbenoxolone is synthesized) has been removed. (Russell & Dickie 1968 , Tewari & Trembalowicz 1968 , Turpie et al. 1968 ). These suggest that the preparation (Caved-S) may be as effective as carbenoxolone but free from side-effects of fluid retention. In two of these trials the number of patients given Caved-S was very small and the total number so treated in all these trials combined (30) needs increasing before the treatment can be confidently recommended. There is also evidence, which again needs confirmation, that an antipeptic agent (Amylopectin sulphate) will considerably accelerate ulcer healing (Zimmon et a!. 1969). Relapse of symptoms of gastric ulcer is common, but so far no treatment has been clearly shown to reduce the relapse rate, which is probably similar in those patients given carbenoxolone and in those whose ulcers heal following simple management by bed rest and stopping smoking.
Duodenal Ulcer
Because of the problems of radiological assessment the analysis of the results of duodenal ulcer treatment has substantially depended upon comparing symptomatic responses. The difficulties inherent in such trials are illustrated by the repeated attempts which have been made to measure the effects of anticholinergic drugs. Modem preparations, which tend to be quaternary ammonium compounds, have been claimed to have a more selective anti-secretory effect than atropine, but the evidence that they are clinically useful is by no means convincing. Synthetic anticholinergic drugs have been claimed to produce better symptomatic responses than atropine or placebo tablets (Ruffin & Cayer 1962) , and tricyclamol and glycopyrronium have been claimed to reduce the chances of ulcer relapse and complications respectively (Sun 1962 (Sun , 1964 . By contrast a marginally better initial symptomatic response obtained with methantheline compared with a placebo was not maintained later (Friedlander 1954 ) and further trials conducted with glycopyrronium, and glycopyrronium or hyoscyamine in maximal doses, respectively showed no difference in the incidence of relapse, or the rate of symptomatic improvement when compared with the responses to dummy tablets (Trevino et al. 1967 , Kaye et al. 1970 ; results which are in accord with others obtained using synthetic anticholinergic com-pounds (Melrose & Pinkerton 1961 , Lennard Jones 1961 .
Results obtained with other treatments seem equally confused; stilbcestrol was found to be an effective duodenal ulcer treatment (Truelove 1960) but aestriol, used because of its greater freedom from side-effects, was not (Connell et al. 1966 ). Since carbenoxolone is substantially absorbed from the stomach a capsule has been designed to burst and release its contents directly into the antrum on the theoretical basis that healing is due to a direct contact effect. Here again evidence in favour of the treatment (Craig et al. 1967 , Amure 1970 is counterbalanced by evidence to the contrary (Colin Jones et al. 1968 , Cliff & Milton-Thompson 1970 . Amylopectin sulphate has also recently been said to reduce the chances of duodenal ulcer relapse (Sun & Ryan 1970) , but this claim needs confirmation. The present confusion about the value of duodenal ulcer treatments is only likely to be resolved by better methods of assessment of ulcer healing, and fibreoptic duodenoscopy may perhaps supply this solution. Despite the intense efforts of many skilled investigators throughout the world, the sad fact remains that we do not know the basic causes of peptic ulcer. We are slowly advancing towards a better understanding of the condition but it seems unlikely that a specific cure will appear except perhaps by chance. Therefore, surgical therapy will probably continue to play an important role in the management of peptic ulcer. This paper will for the most part consider the choice of operation for gastric and duodenal ulcer, but two preliminary general observations are pertinent to put the subject in a proper surgical perspective.
First, there is no strictly acceptable evidence that surgical therapy for peptic ulcer is better than medical therapy. This may sound a mildly ,heretical statement from a surgeon but, nevertheless, even in a carefully selected group of patients, surgery generates a whole set of new problems which must be balanced against the benefit of the cure of peptic ulcer and its complications. Traditionally these new problems comprise early post-operative death, recurrent ulceration, symptomatic disorders and malnutrition; but we should not forget the nonspecific morbidity of any abdominal operation such as deep vein thrombosis, incisional hernia and chest infection. Unfortunately none of these factors can be quantified so that it is impossible to draw up an accurate profit and loss account, and any final decision must depend on personal judgment based on the available facts.
Secondly, there is still no certain means of knowing how to select individual patients for operation. The working assumption is that operation is indicated if the patient has had a lot of trouble with his ulcer for a long time. We would do better to operate in advance of the trouble and thus prevent it. This involves predictions about the fate of individual patients, but as yet we cannot foresee which will do well and which badly.
Against the background of these two fundamental uncertainties, I will discuss the surgical approach first to gastric and then to duodenal ulcer.
Gastric Ulcer Until fairly recently, there was little really useful information on the cause of gastric ulcer and its surgical treatment was non-controversialpar-
